Number of participating innovations and countries per year 2007-2024

Country

Spain

Prize

Innovation of Innovations & Award Winner of Health Care Sector Innovations

Organization

MIKROBIOMIK HEALTHCARE COMPANY S.L.

Innovation

MBK-01, THE FIRST NON-ANTIBIOTIC ANTIBIOTIC.

Description

MBK-01 is an innovative biological drug based on gut microbiota to treat infections caused by the bacterium Clostridioides difficile, which leads to severe diarrhea, without the use of conventional antibiotics.

Country

Spain

Prize

Award Winner of Potential Innovations

Organization

UNIVERSIDAD DE ZARAGOZA

Innovation

Hollow Fibre System Technologies – Value for Pharma, Biotech, Health Care Systems and Society.

Description

The Hollow Fibre System accelerates drug development, reduces costs and animal usage, and lowers the risk of clinical failure. We have implemented the largest Biosafety Level 3 capacity in Europe.

Country

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Prize

Award Winner of Circular Economy and Carbon Neutrality Innovations

Organization

SEGUAS AIRE COMPRIMIDO Y FRIO INDUSTRIAL SLU

Innovation

SEGUAS' Duoenergy System to Reduce Gas Consumption as Much as Possible and Decarbonise Industry

Description

DuoEnergy system recovers up to 136% of the cooling energy of a chiller in the form of heat to be able to air condition an industrial warehouse or reuse it in other industrial processes.

Country

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Prize

Award Winner of Education Sector Innovations

Organization

China Guangfa Bank Co., Ltd.(CGB) Credit Card Center

Innovation

The Innovation of a Comprehensive Full-Process Smart Anti-Telecom Fraud Education System

Description

To improve financial literacy and meet the need for effective education, this innovation integrates the OECD Framework and utilizes real-time computing, machine learning, and big data. CGB developed an anti-fraud education system that boosts public fraud prevention awareness. In 2023, it educated over 10 million people and intercepted RMB 30 million in losses, enhancing financial security.

Country

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Prize

Award Winner of Public Sector Innovations

Organization

Xiamen Airlines

Innovation

Digital-Driven Innovation in Xiamen Airlines’ Flight Data Management and Application

Description

This project uses the PDCA method to develop 53 flight data models, achieving over 99% accuracy in detecting risks and enhancing safety through digital decision-making. Xiamen Airlines has logged 8.6 million safe flight hours, with an incident rate of 0.005—well below the global average—and saves 79 million EUR annually in fuel and maintenance costs.

Country

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Prize

Award Winner of Business Innovations (Micro & Startup Companies)

Organization

SURPHASE

Innovation

Operational Excellence in Water Desalination Plants Through Innovative Sensor Nanotechnology

Description

A device featuring a disruptive, patented sensor nanotechnology that proactively detects and monitors membrane fouling and cleaning efficiency in real time, using a non-invasive approach.

Country

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Prize

Award Winner of Business Innovations (Small and Medium Sized Enterprises)

Organization

LABORATORIOS TECNOLÓGICOS DE LEVANTE, S.L. 

Innovation

Environmental Genomics for Environmental and Water Quality Monitoring

Description

Development of a new DNA-based test for the identification of benthic diatoms in European water bodies.

Country

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Prize

Award Winner of Business Innovations (Large Companies)

Organization

Xingtai Iron and Steel Corp., Ltd.

Innovation

Technological Innovation and Application of High Strength and Ultra-Clean Cold Heading Steel for New Energy Vehicle

Description

Through mechanism research, numerical simulation, quality design and production test, this project has developed high-end cold heading steel for new energy vehicles, and its technology has reached the international advanced level.

Country

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Prize

Prize Winner of Potential Innovations

Organization

Beijing Institute of Precision Mechatronics and Controls

Innovation

The Development and Application of the Exoskeleton Intelligent Recognition System

Description

This innovation developed an adaptive exoskeleton system with 97.28% accuracy, balancing generalization and individual differences. Using the QFD-FMEA model, it enhanced usability and safety. Deployed in two fire stations, it improved efficiency and reduced firefighter strain.

Country

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Prize

Prize Winner of Potential Innovations

Organization

Municipality of 13th District of Capital Budapest

Innovation

Smart Kindergarten with Smart Kids: When Dreams Become Reality.

Description

The integration of intelligent architectural design and operational strategies, coupled with the utilisation of digital pedagogical tools, collectively shape the digital ecosystem.

Country

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Prize

Prize Winner of Circular Economy and Carbon Neutrality Innovations

Organization

Metsä Group Plus

Innovation

Metsä Group Plus

Description

Metsä Group Plus is a forest management model aimed at enhancing biodiversity and improving the state of forest nature. This model was introduced in June 2023 and offers owner-members the opportunity to conduct forestry work with more extensive nature conservation measures than before.

Country

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Prize

Prize Winner of Circular Economy and Carbon Neutrality Innovations

Organization

PTT LNG Co., Ltd.

Innovation

Green Future: Carbon Neutral Buildings Harnessing LNG Cold Energy

Description

This pioneering building sets a new standard in energy efficiency and carbon neutrality. Designed with extensive glass walls and roofing, it maximizes natural light, reducing the need for artificial lighting. The air conditioning system leverages cold energy from LNG regasification technology, cutting power consumption by over 50% compared to conventional systems. With the addition of a solar rooftop and wind turbine, the building is now powered by its own renewable energy source during the daytime, ensuring sustainable and green operations.

Country

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Prize

Prize Winner of Health Care Sector Innovations

Organization

Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd., Baiyunshan Pharmaceutical General Factory

Innovation

Development of a New Method for Measuring Particle Size of Drugs

Description

This project developed a new drug particle size measurement method by classifying samples, using liquid-airflow dispersion to prevent agglomeration, and applying light scattering for diverse particle shapes. The method has a 15-day development cycle, 100% validation success, and offers efficient, accurate measurement.

Country

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Prize

Prize Winner of Health Care Sector Innovations

Organization

MEDICOR Elektronika Zrt.

Innovation

AI-enabled Data Collection and Analysis Hospital Data Concentrator System

Description

The Data Concentrator will raise the quality and safety of neonatal intensive care (PIC) to a high level, connect to the hospitals' information system (HIS) and reduce the need for human resources.

Country

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Prize

Prize Winner of Education Sector Innovations

Organization

Amadip Esment Foundation

Innovation

Esment Escola Professional, An Educational and Social Innovation Project Transferable to Spain and Europe

Description

Esment Escola Professional is an educational innovation project (pioneer in Spain), promoted by Amadip Esment Foundation (AEF), a social organisation in Mallorca (Balearic Islands), which transfers and shares its learning with other contexts and territories.

Country

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Prize

Prize Winner of Education Sector Innovations

Organization

Eötvös Loránd University, Faculty of Economics

Innovation

Resource Optimization of University Exams to Improve Service Quality at ELTE Faculty of Economics

Description

The new approach is based on the idea of creating an innovative solution to the assessment service. The task of organizing and administering of all faculty-related exams are removed from the traditional teaching tasks. The administration of the exams has become the responsibility of a single, autonomous unit, the Exam Centre, which has its own optimally sized resource capacity and standardized procedure.

Country

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Prize

Prize Winner of Public Sector Innovations

Organization

Diputación Foral de Gipuzkoa (Provincial Council of Gipuzkoa)

Innovation

Zaintza Herrilab Strategy: Driving the Development of Local Care Ecosystems

Description

Driving the development of local care ecosystems to improve care and services for elderly people living at home, through the collaboration of the elder care ecosystem stakeholders.

Country

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Prize

Prize Winner of Public Sector Innovations

Organization

Municipal Library of Jászberény

Innovation

The Creation of the Folktale Section of JÁSzsÁG in the Library of JÁSzberÉNy as Library Innovation

Description

The Folktale Section of Jászság can only be found in our library in the whole country. Its aims are tradition, the re-recognition of read aloud storytelling, the tale and education to become a reader.

Country

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Prize

Prize Winner of Business Innovations (Micro & Startup Companies)

Organization

Conqum Systems Ltd.

Innovation

CONQUM - CONstruction QUality Management and Control System

Description

CONQUM is a patented automated construction quality management system applicable to any project type. It enables users to monitor and control every detail of construction progress, adhering to adjustable quality standards. Designed to address the growing complexity of construction projects, it helps project managers identify failures, track deviations, and generate reports efficiently. With advanced automation and real-time updates via mobile or tablet, CONQUM improves process control, prevents errors, and enhances project efficiency and quality.

Country

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Prize

Prize Winner of Business Innovations (Micro & Startup Companies)

Organization

MyBusDirect Zrt.

Innovation

Mybusdirect – Industry 4.0 Begins with Employee Transportation

Description

MyBusDirect creates a Sustainable Transportation Ecosystem, offering financial savings and environmental benefits, leading to a more sustainable and efficient future where cost-effectiveness and environmental awareness prevail.

Country

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Prize

Prize Winner of Business Innovations (Small & Medium-sized Enterprises)

Organization

Beijing Institute of Near-space Vehicle's Systems Engineering

Innovation

Development of Aircraft Antenna Window Product Portfolio and Recommendation Platform

Description

The quality innovation optimizes the design and manufacture of antenna windows. It has established an recommendation platform and a product portfolio, approved as Chinese national military standard.

Country

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Prize

Prize Winner of Business Innovations (Large Companies)

Organization

Elisa Oyj, ltd

Innovation

The Battle Against Scam Calls

Description

In Finland and around the world, many scam calls are made to citizens. These scam calls aim to extract money from citizens or gain some other advantage. Elisa Oyj's automated system detects scam calls and has reduced their number by over 90 percent in Finland alone. The system utilizes artificial intelligence and identifies scam calls within hundredths of a second. The system is scalable for worldwide use and adaptable to all language regions.

Country

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Prize

Prize Winner of Business Innovations (Large Companies)

Organization

CELULOSAS DE ASTURIAS S.A.U

Innovation

Zero Odour Project. Improvement of Environmental Performance to Obtain the Social License

Description

The management of environmental aspects is evaluated beyond the Legal Framework, adapting the company's environmental performance to the requirements of society and stakeholders through BAT.

Country

Prize

Organization

Innovation

Description

Text